Literature DB >> 4011635

Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons.

M J Pontecorvo, H L Evans.   

Abstract

A 3-choice, variable-delay, matching-to-sample procedure was used to evaluate drugs in both pigeons and monkeys while tested under nearly-identical conditions. Aniracetam (Roche 13-5057) improved accuracy of matching at all retention intervals following oral administration (12.5, 25 and 50 mg/kg) to macaque monkeys, with a maximal effect at 25 mg/kg. Aniracetam also antagonized scopolamine-induced impairment of the monkey's performance. Intramuscular administration of these same doses of aniracetam produced a similar, but not significant trend toward improved matching accuracy in pigeons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4011635     DOI: 10.1016/0091-3057(85)90523-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

Authors:  M L Woolley; K A Waters; J E Gartlon; L P Lacroix; C Jennings; F Shaughnessy; A Ong; D J Pemberton; M H Harries; E Southam; D N C Jones; L A Dawson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

4.  Effect of combined or separate administration of piracetam and choline on learning and memory in the rat.

Authors:  A Ennaceur; J Delacour
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Authors:  Mark D Black
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

6.  7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.

Authors:  D M Thompson; A Guidotti; M DiBella; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.

Authors:  Bethany Plakke; Chi-Wing Ng; Amy Poremba
Journal:  Neurosci Lett       Date:  2008-04-10       Impact factor: 3.046

8.  Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination.

Authors:  R C Kirk; K G White; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine.

Authors:  J J Hagan; J H Jansen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Aniracetam does not improve working memory in neurologically healthy pigeons.

Authors:  Hannah Phillips; Arlene McDowell; Birgitte S Mielby; Ian G Tucker; Michael Colombo
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.